These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29267063)

  • 1. Mortality Among Confirmed Lassa Fever Cases During the 2015-2016 Outbreak in Nigeria.
    Buba MI; Dalhat MM; Nguku PM; Waziri N; Mohammad JO; Bomoi IM; Onyiah AP; Onwujei J; Balogun MS; Bashorun AT; Nsubuga P; Nasidi A
    Am J Public Health; 2018 Feb; 108(2):262-264. PubMed ID: 29267063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-emerging Lassa fever outbreaks in Nigeria: Re-enforcing "One Health" community surveillance and emergency response practice.
    Tambo E; Adetunde OT; Olalubi OA
    Infect Dis Poverty; 2018 Apr; 7(1):37. PubMed ID: 29703243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Containing a Lassa fever epidemic in a resource-limited setting: outbreak description and lessons learned from Abakaliki, Nigeria (January-March 2012).
    Ajayi NA; Nwigwe CG; Azuogu BN; Onyire BN; Nwonwu EU; Ogbonnaya LU; Onwe FI; Ekaete T; Günther S; Ukwaja KN
    Int J Infect Dis; 2013 Nov; 17(11):e1011-6. PubMed ID: 23871405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiologic and Clinical Features of Lassa Fever Outbreak in Nigeria, January 1-May 6, 2018.
    Ilori EA; Furuse Y; Ipadeola OB; Dan-Nwafor CC; Abubakar A; Womi-Eteng OE; Ogbaini-Emovon E; Okogbenin S; Unigwe U; Ogah E; Ayodeji O; Abejegah C; Liasu AA; Musa EO; Woldetsadik SF; Lasuba CLP; Alemu W; Ihekweazu C;
    Emerg Infect Dis; 2019 Jun; 25(6):1066-1074. PubMed ID: 31107222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lassa fever outcomes and prognostic factors in Nigeria (LASCOPE): a prospective cohort study.
    Duvignaud A; Jaspard M; Etafo IC; Gabillard D; Serra B; Abejegah C; le Gal C; Abidoye AT; Doutchi M; Owhin S; Séri B; Vihundira JK; Bérerd-Camara M; Schaeffer J; Danet N; Augier A; Ogbaini-Emovon E; Salam AP; Ahmed LA; Duraffour S; Horby P; Günther S; Adedosu AN; Ayodeji OO; Anglaret X; Malvy D;
    Lancet Glob Health; 2021 Apr; 9(4):e469-e478. PubMed ID: 33740408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with delayed presentation to healthcare facilities for Lassa fever cases, Nigeria 2019: a retrospective cohort study.
    Chandra NL; Bolt H; Dan-Nwafor C; Ipadeola O; Ilori E; Namara G; Olayinka AT; Ukponu W; Iniobong A; Amedu M; Akano A; Akabike KO; Okhuarobo U; Fagbemi S; Sampson E; Newitt S; Verlander NQ; Bausch DG; le Polain de Waroux O; Ihekweazu C
    BMC Infect Dis; 2021 Feb; 21(1):143. PubMed ID: 33541278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measures to control protracted large Lassa fever outbreak in Nigeria, 1 January to 28 April 2019.
    Dan-Nwafor CC; Furuse Y; Ilori EA; Ipadeola O; Akabike KO; Ahumibe A; Ukponu W; Bakare L; Okwor TJ; Joseph G; Mba NG; Akano A; Olayinka AT; Okoli I; Okea RA; Makava F; Ugbogulu N; Oladele S; Namara G; Muwanguzi EN; Naidoo D; Mutbam SK; Okudo I; Woldetsadik SF; Lasuba CL; Ihekweazu C
    Euro Surveill; 2019 May; 24(20):. PubMed ID: 31115314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early onset of neurological features differentiates two outbreaks of Lassa fever in Ebonyi state, Nigeria during 2017-2018.
    Chika-Igwenyi NM; Harrison RE; Psarra C; Gil-Cuesta J; Gulamhusein M; Onwe EO; Onoh RC; Unigwe US; Ajayi NA; Nnadozie UU; Ojide CK; Nwidi DU; Ezeanosike O; Sampson E; Adeke AS; Ugwu CN; Anebonam U; Tshiang JK; Maikere J; Reid A
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009169. PubMed ID: 33684118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular diagnostics for lassa fever at Irrua specialist teaching hospital, Nigeria: lessons learnt from two years of laboratory operation.
    Asogun DA; Adomeh DI; Ehimuan J; Odia I; Hass M; Gabriel M; Olschläger S; Becker-Ziaja B; Folarin O; Phelan E; Ehiane PE; Ifeh VE; Uyigue EA; Oladapo YT; Muoebonam EB; Osunde O; Dongo A; Okokhere PO; Okogbenin SA; Momoh M; Alikah SO; Akhuemokhan OC; Imomeh P; Odike MA; Gire S; Andersen K; Sabeti PC; Happi CT; Akpede GO; Günther S
    PLoS Negl Trop Dis; 2012; 6(9):e1839. PubMed ID: 23029594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in Lassa Fever Cases in Nigeria, January-March 2018.
    Ilori EA; Frank C; Dan-Nwafor CC; Ipadeola O; Krings A; Ukponu W; Womi-Eteng OE; Adeyemo A; Mutbam SK; Musa EO; Lasuba CLP; Alemu W; Okogbenin S; Ogbaini E; Unigwe U; Ogah E; Onoh R; Abejegah C; Ayodeji O; Ihekweazu C
    Emerg Infect Dis; 2019 May; 25(5):1026-1027. PubMed ID: 30807268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection pattern, case fatality rate and spread of Lassa virus in Nigeria.
    Yaro CA; Kogi E; Opara KN; Batiha GE; Baty RS; Albrakati A; Altalbawy FMA; Etuh IU; Oni JP
    BMC Infect Dis; 2021 Feb; 21(1):149. PubMed ID: 33546623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital-based surveillance for Lassa fever in Edo State, Nigeria, 2005-2008.
    Ehichioya DU; Asogun DA; Ehimuan J; Okokhere PO; Pahlmann M; Olschläger S; Becker-Ziaja B; Günther S; Omilabu SA
    Trop Med Int Health; 2012 Aug; 17(8):1001-4. PubMed ID: 22594713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and laboratory predictors of Lassa fever outcome in a dedicated treatment facility in Nigeria: a retrospective, observational cohort study.
    Okokhere P; Colubri A; Azubike C; Iruolagbe C; Osazuwa O; Tabrizi S; Chin E; Asad S; Ediale E; Rafiu M; Adomeh D; Odia I; Atafo R; Aire C; Okogbenin S; Pahlman M; Becker-Ziaja B; Asogun D; Fradet T; Fry B; Schaffner SF; Happi C; Akpede G; Günther S; Sabeti PC
    Lancet Infect Dis; 2018 Jun; 18(6):684-695. PubMed ID: 29523497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cluster of nosocomial Lassa fever cases in a tertiary health facility in Nigeria: Description and lessons learned, 2018.
    Dan-Nwafor CC; Ipadeola O; Smout E; Ilori E; Adeyemo A; Umeokonkwo C; Nwidi D; Nwachukwu W; Ukponu W; Omabe E; Anaebonam U; Igwenyi N; Igbodo G; Eteng W; Uzoma I; Saleh M; Agboeze J; Mutbam S; de Gooyer T; Short R; Aniaku E; Onoh R; Ogah E; Nguku P; Oladejo J; Peter C; Ojo O; Ihekweazu C
    Int J Infect Dis; 2019 Jun; 83():88-94. PubMed ID: 30930184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with progression to death in patients with Lassa fever in Nigeria: an observational study.
    Strampe J; Asogun DA; Speranza E; Pahlmann M; Soucy A; Bockholt S; Pallasch E; Becker-Ziaja B; Duraffour S; Bhadelia N; Ighodalo Y; Oyakhilome J; Omomoh EO; Olokor T; Adomeh DI; Ikponwonsa O; Aire C; Tobin E; Akpede N; Okokhere PO; Okogbenin SA; Akpede GO; Muñoz-Fontela C; Ogbaini-Emovon E; Günther S; Connor JH; Oestereich L
    Lancet Infect Dis; 2021 Jun; 21(6):876-886. PubMed ID: 33484646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving Cross-Border Preparedness and Response: Lessons Learned from 3 Lassa Fever Outbreaks Across Benin, Nigeria, and Togo, 2017-2019.
    Kakaī CG; Okunromade OF; Dan-Nwafor CC; Chabi AIB; Martial GTP; Dalhat MM; Ward S; Tante O; Nguku PM; Hamadi A; Ilori E; Lokossou V; Brito C; Ojo OE; Kone I; Agbeko TT; Ihekweazu C; Merrill RD
    Health Secur; 2020 Jan; 18(S1):S105-S112. PubMed ID: 32004125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constraints in the diagnosis and treatment of Lassa Fever and the effect on mortality in hospitalized children and women with obstetric conditions in a rural district hospital in Sierra Leone.
    Dahmane A; van Griensven J; Van Herp M; Van den Bergh R; Nzomukunda Y; Prior J; Alders P; Jambai A; Zachariah R
    Trans R Soc Trop Med Hyg; 2014 Mar; 108(3):126-32. PubMed ID: 24535150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of lassa Fever in Nigeria.
    Inegbenebor U; Okosun J; Inegbenebor J
    Trans R Soc Trop Med Hyg; 2010 Jan; 104(1):51-4. PubMed ID: 19712954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice.
    Fisher-Hoch SP; Tomori O; Nasidi A; Perez-Oronoz GI; Fakile Y; Hutwagner L; McCormick JB
    BMJ; 1995 Sep; 311(7009):857-9. PubMed ID: 7580496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological trends of Lassa fever in Nigeria, 2018-2021.
    Dalhat MM; Olayinka A; Meremikwu MM; Dan-Nwafor C; Iniobong A; Ntoimo LF; Onoh I; Mba S; Ohonsi C; Arinze C; Esu EB; Nwafor O; Oladipupo I; Onoja M; Ilori E; Okonofua F; Ochu CL; Igumbor EU; Adetifa I
    PLoS One; 2022; 17(12):e0279467. PubMed ID: 36584167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.